V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310010452 | 310007756 | 1.8 | 82 | Palliative (P) | 2014-04-04 | 2014-08-22 | GEMCITABINE | N | null | 310015077 | GEMCITABINE |
| 310010454 | 310007757 | 1.75 | null | null | 2016-04-25 | 2016-04-25 | Mini BEAM | 2 | N | 310015114 | BEAM |
| 310010456 | 310004223 | 1.73 | 85.8 | Curative (C) | 2019-01-09 | 2019-01-09 | CISPLATIN + GEMCITABINE | 2 | N | 310015279 | CISPLATIN + GEMCITABINE |
| 310010457 | 310004227 | 1.78 | null | Disease modification (D) | 2017-10-28 | 2017-11-02 | CISPLATIN + GEMCITABINE | 02 | null | 310015321 | CISPLATIN + GEMCITABINE |
| 310010458 | 310011527 | null | 74.9 | Curative (C) | 2019-02-18 | 2019-03-05 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310015328 | CISPLATIN + GEMCITABINE |
| 310010459 | 310004244 | 1.65 | 61.5 | Disease modification (D) | 2017-05-02 | 2017-05-02 | CISPLATIN + GEMCITABINE | N | null | 310015424 | CISPLATIN + GEMCITABINE |
| 310010460 | 310004245 | 1.71 | 79.7 | Curative (C) | 2015-11-04 | 2015-11-17 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310015428 | CISPLATIN + GEMCITABINE |
| 310010461 | 310004254 | 1.75 | null | Curative (C) | 2019-03-08 | 2019-03-09 | LEAM | N | N | 310015475 | LEAM |
| 310010462 | 310004258 | 1.8 | 93.6 | Palliative (P) | 2014-07-21 | 2014-07-21 | PEMBROLIZUMAB | 2 | null | 310015487 | PEMBROLIZUMAB |
| 310010463 | 310004262 | 1.56 | 14.4 | Palliative (P) | 2015-01-27 | 2015-02-02 | Carboplatin + Liposomal Doxorubicin | N | N | 310015581 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010464 | 310004264 | 1.73 | 86.6 | Palliative (P) | 2018-08-03 | 2018-08-06 | LEAM | N | N | 310015599 | LEAM |
| 310010465 | 310004265 | 1.68 | 77 | Curative (C) | 2015-12-22 | 2016-01-11 | BEAM | N | N | 310015639 | BEAM |
| 310010466 | 310007782 | 1.76 | 81.7 | Palliative (P) | 2017-05-10 | 2017-05-10 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310015670 | CISPLATIN + GEMCITABINE |
| 310010467 | 310004269 | 1.77 | 50.5 | Curative (C) | 2016-06-13 | 2016-11-04 | PEMBROLIZUMAB | null | null | 310015687 | PEMBROLIZUMAB |
| 310010468 | 310004275 | null | 71.5 | Curative (C) | 2014-10-21 | 2014-10-21 | PEMBROLIZUMAB | 02 | N | 310015755 | PEMBROLIZUMAB |
| 310010469 | 310004276 | 1.63 | 76 | Palliative (P) | 2016-12-29 | 2017-02-12 | Brentuximab | Y | null | 310015767 | BRENTUXIMAB |
| 310010470 | 310004282 | 1.77 | null | Palliative (P) | 2015-04-11 | 2015-04-22 | PEMBROLIZUMAB | N | N | 310015863 | PEMBROLIZUMAB |
| 310010471 | 310004286 | 1.65 | 96.3 | Curative (C) | 2017-04-09 | 2018-04-13 | LEAM | N | Y | 310015897 | LEAM |
| 310010472 | 310004287 | 1.72 | null | Palliative (P) | 2014-10-13 | 2014-11-23 | Carboplatin + Liposomal Doxorubicin | N | N | 310015911 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010473 | 310004288 | 1.57 | 70 | Palliative (P) | 2019-05-13 | 2019-05-29 | PEMBROLIZUMAB | N | N | 310015915 | PEMBROLIZUMAB |
| 310010474 | 310004296 | 1.75 | 19.15 | Curative (C) | 2017-02-12 | 2017-02-12 | LEAM | N | N | 310016025 | LEAM |
| 310010475 | 310007797 | 1.57 | 58.9 | Disease modification (D) | 2011-10-23 | 2014-05-29 | BEAM | N | N | 310016112 | BEAM |
| 310010476 | 310004308 | 1.76 | 89 | Curative (C) | 2017-05-26 | 2018-11-02 | LEAM | 2 | N | 310016129 | LEAM |
| 310010477 | 310004311 | 0 | 69.6 | Palliative (P) | 2011-06-26 | 2015-09-09 | Carboplatin + Liposomal Doxorubicin | 2 | null | 310016142 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010478 | 310010658 | 1.9 | null | Palliative (P) | 2014-02-01 | 2014-09-01 | Brentuximab | N | N | 310016157 | BRENTUXIMAB |
| 310010479 | 310004319 | 1.73 | null | Curative (C) | null | 2019-08-12 | IVE | N | N | 310016231 | IVE |
| 310010480 | 310004326 | 1.59 | null | Palliative (P) | 2014-01-12 | 2014-07-06 | Carboplatin + Liposomal Doxorubicin | N | N | 310016303 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010481 | 310004331 | 1.73 | 56.6 | Palliative (P) | 2014-08-26 | 2014-09-02 | Carboplatin + Liposomal Doxorubicin | 2 | Y | 310016377 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010482 | 310004338 | null | 89.6 | Palliative (P) | 2016-06-16 | 2016-09-01 | PEMBROLIZUMAB | 2 | Y | 310016471 | PEMBROLIZUMAB |
| 310010484 | 310004342 | null | null | Curative (C) | 2014-12-12 | 2015-01-14 | Carboplatin + Liposomal Doxorubicin | N | N | 310016481 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010485 | 310004342 | null | null | Palliative (P) | 2018-08-27 | 2018-11-12 | CISPLATIN + GEMCITABINE | N | N | 310016481 | CISPLATIN + GEMCITABINE |
| 310010486 | 310004347 | 1.96 | null | Curative (C) | 2015-11-01 | 2015-11-29 | IVE | N | N | 310016629 | IVE |
| 310010487 | 310004350 | 1.53 | 57.9 | Curative (C) | 2015-04-23 | 2016-09-14 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | 2 | N | 310016633 | NOT MATCHED |
| 310010488 | 310004354 | 1.68 | 57.7 | Palliative (P) | null | 2018-03-19 | PEMBROLIZUMAB | 02 | N | 310016669 | PEMBROLIZUMAB |
| 310010489 | 310004357 | 1.72 | 77 | Palliative (P) | 2017-07-28 | 2017-08-30 | Carboplatin + Liposomal Doxorubicin | N | null | 310016672 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010490 | 310011721 | 1.5 | 51 | Disease modification (D) | 2016-04-28 | 2016-09-25 | Brentuximab | N | N | 310016722 | BRENTUXIMAB |
| 310010491 | 310007825 | 1.68 | 120 | Curative (C) | 2016-10-16 | 2016-10-21 | BEAM | N | N | 310016795 | BEAM |
| 310010492 | 310004364 | 1.6 | null | Neo-adjuvant (N) | 2016-01-30 | 2016-02-26 | Carboplatin + Liposomal Doxorubicin | 02 | null | 310016833 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010493 | 310004370 | 1.75 | 96.6 | Curative (C) | 2019-01-05 | 2019-03-03 | CNS Pineoblastoma guidelines Vinc/Etop/Cyclophos | N | N | 310016840 | NOT MATCHED |
| 310010494 | 310004378 | 1.6 | 61.2 | Curative (C) | 2019-05-29 | 2019-06-05 | CISPLATIN + GEMCITABINE | 02 | Y | 310016898 | CISPLATIN + GEMCITABINE |
| 310010495 | 310007833 | 1.55 | 72.2 | Palliative (P) | 2018-04-25 | 2018-09-01 | Carboplatin + Liposomal Doxorubicin | N | N | 310016909 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010496 | 310004383 | null | 80 | Neo-adjuvant (N) | 2016-01-04 | 2016-06-24 | CISPLATIN + GEMCITABINE | N | N | 310016931 | CISPLATIN + GEMCITABINE |
| 310010498 | 310004390 | 1.77 | 81.7 | Palliative (P) | 2018-08-13 | 2018-08-22 | PEMBROLIZUMAB | null | null | 310017045 | PEMBROLIZUMAB |
| 310010499 | 310004393 | 1.65 | 111.3 | Palliative (P) | 2015-10-07 | 2015-10-14 | Carboplatin + Liposomal Doxorubicin | N | N | 310017080 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010500 | 310009684 | 1.64 | 93.5 | Palliative (P) | 2014-06-30 | 2014-07-20 | Brentuximab Vedotin | N | N | 310017082 | BRENTUXIMAB |
| 310010501 | 310004399 | 1.6 | 67.55 | Palliative (P) | null | 2016-11-14 | Brentuximab Vedotin | 02 | N | 310017155 | BRENTUXIMAB |
| 310010502 | 310004403 | 1.68 | 82 | Palliative (P) | 2015-06-14 | 2015-08-07 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 310017198 | GEMCITABINE |
| 310010503 | 310004407 | 1.73 | 94.3 | Palliative (P) | 2018-03-23 | 2018-05-09 | CISPLATIN + GEMCITABINE | Y | N | 310017235 | CISPLATIN + GEMCITABINE |
| 310010504 | 310004409 | null | null | Curative (C) | 2018-01-03 | 2018-01-08 | IVE | 02 | N | 310017252 | IVE |
| 310010505 | 310004411 | 1.76 | 85.7 | null | 2015-02-06 | 2015-03-21 | BEAM | Y | N | 310017258 | BEAM |